- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +49 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
- Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Clinical trial condition
Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Explore clinical trials studying Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive. Study availability and eligibility vary by location and protocol.
14 public trials
3 recruiting studies
Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive trial results
NCT01527045
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Blood Protein Disorders, +57 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00105001
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
Active, Not Recruiting
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
NCT02861417
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States